Mehlika Dilek Altintop (Mehlika Dilek Altıntop, Mehlika D Altıntop)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 23

Top Topics

Molecular Docking

Oxidative Stress

Top Venues

International journal of molecular sciences

Molecules (Basel, Switzerland)

Archiv der Pharmazie

This page only lists publications with an associated author ORCID identifier.

Publications

Iman Baramaki, Mehlika Dilek Altintop, Rana Arslan, Feyza Alyu Altınok, Ahmet Özdemir, Ilhem Dallali, Ahmed Hasan, Nurcan Bektaş Türkmen
Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents. ACS omega 9 (10) (2024)
Iman Baramaki, Mehlika Dilek Altintop, Rana Arslan, Feyza Alyu Altınok, Ahmet Özdemir, Ilhem Dallali, Ahmed Hasan, Nurcan Bektaş Türkmen
Design, Synthesis, and In Vivo Evaluation of a New Series of Indole-Chalcone Hybrids as Analgesic and Anti-Inflammatory Agents. ACS omega 9 (10) (2024)
Mehlika Dilek Altintop, Begüm Nurpelin Sağlık Özkan, Ahmet Özdemir
Design, Synthesis, and Evaluation of New Pyrazolines As Small Molecule Inhibitors of Acetylcholinesterase. ACS omega 9 (29) (2024)
Mehlika Dilek Altintop, Begüm Nurpelin Sağlık Özkan, Ahmet Özdemir
Design, Synthesis, and Evaluation of New Pyrazolines As Small Molecule Inhibitors of Acetylcholinesterase. ACS omega 9 (29) (2024)
Mehlika Dilek Altintop, Gülşen Akalın Çiftçi, Nalan Yılmaz Savaş, İpek Ertorun, Betül Can, Belgin Sever, Halide Edip Temel, Özkan Alataş, Ahmet Özdemir
Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action. International journal of molecular sciences 24 (3) (2023)
Mehlika Dilek Altintop, Malihe Moradzadeh, Cüneyt Türkeş, Remzi B Öztürk, Zerrin Cantürk, Sukru Beydemir, Ahmet Özdemir
A new series of hydrazones as small-molecule aldose reductase inhibitors. Archiv der Pharmazie (2023)
Mehlika Dilek Altintop, Gülşen Akalın Çiftçi, Nalan Yılmaz Savaş, İpek Ertorun, Betül Can, Belgin Sever, Halide Edip Temel, Özkan Alataş, Ahmet Özdemir
Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action. International journal of molecular sciences 24 (3) (2023)
Burak Erdönmez, Mehlika Dilek Altintop, Gülşen Akalın Çiftçi, Ahmet Özdemir, Abdulilah Ece
Design, Synthesis, and Evaluation of a New Series of Hydrazones as Small-Molecule Akt Inhibitors for NSCLC Therapy. ACS omega 8 (22) (2023)
Mehlika Dilek Altintop, Zerrin Cantürk, Ahmet Özdemir
Design, Synthesis, and Evaluation of a New Series of 2-Pyrazolines as Potential Antileukemic Agents. ACS omega 8 (45) (2023)
Mehlika Dilek Altintop, Gülşen Akalın Çiftçi, Nalan Yılmaz Savaş, İpek Ertorun, Betül Can, Belgin Sever, Halide Edip Temel, Özkan Alataş, Ahmet Özdemir
Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action. International journal of molecular sciences 24 (3) (2023)
Mehlika Dilek Altintop, Gülşen Akalın Çiftçi, Nalan Yılmaz Savaş, İpek Ertorun, Betül Can, Belgin Sever, Halide Edip Temel, Özkan Alataş, Ahmet Özdemir
Discovery of Small Molecule COX-1 and Akt Inhibitors as Anti-NSCLC Agents Endowed with Anti-Inflammatory Action. International journal of molecular sciences 24 (3) (2023)
Mehlika Dilek Altintop, Belgin Sever, Gülşen Akalın Çiftçi, İpek Ertorun, İbrahim Ozkan Alatas, Ahmet Özdemir
A new series of thiosemicarbazone-based anti-inflammatory agents exerting their action through cyclooxygenase inhibition. Archiv der Pharmazie 355 (9) (2022)
Ahmet Özdemir, Halilibrahim Çiftçi, Belgin Sever, Hiroshi Tateishi, Masami Otsuka, Mikako Fujita, Mehlika Dilek Altintop
A New Series of Indeno[1,2- c ]pyrazoles as EGFR TK Inhibitors for NSCLC Therapy. Molecules (Basel, Switzerland) 27 (2) (2022)
Turana Orujova, Abdulilah Ece, Gülşen Akalın Çiftçi, Ahmet Özdemir, Mehlika Dilek Altintop
A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancer. Drug development research (2022)
Belgin Sever, Cüneyt Türkeş, Mehlika Dilek Altintop, Malihe Moradzadeh, Gulsen Akalin Ciftci, Sukru Beydemir
Novel metabolic enzyme inhibitors designed through the molecular hybridization of thiazole and pyrazoline scaffolds. Archiv der Pharmazie 354 (12) (2021)
Halilibrahim Çiftçi, Mohamed Osman Radwan, Belgin Sever, Ahmed K Hamdy, Safiye Emirdağ, Nafia Gökçe Ulusoy, Ece Sozer, Mustafa Can, Nurettin Yayli, Norie Araki, Hiroshi Tateishi, Masami Otsuka, Mikako Fujita, Mehlika Dilek Altintop
EGFR-Targeted Pentacyclic Triterpene Analogues for Glioma Therapy. International journal of molecular sciences 22 (20) (2021)
Belgin Sever, Hasan Soybir, Şennur Görgülü, Zerrin Cantürk, Mehlika Dilek Altintop
Pyrazole Incorporated New Thiosemicarbazones: Design, Synthesis and Investigation of DPP-4 Inhibitory Effects. Molecules (Basel, Switzerland) 25 (21) (2020)
Belgin Sever, Gülşen Akalın Çiftçi, Mehlika Dilek Altintop
A new series of benzoxazole-based SIRT1 modulators for targeted therapy of non-small-cell lung cancer. Archiv der Pharmazie 354 (1) (2020)
Belgin Sever, Mehlika Dilek Altintop, Ahmet Özdemir, Gülşen Akalın Çiftçi, Doha E Ellakwa, Hiroshi Tateishi, Mohamed Osman Radwan, Mahmoud A A Ibrahim, Masami Otsuka, Mikako Fujita, Halilibrahim Çiftçi, Taha Farouk Shehata Ali
In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors. Molecules (Basel, Switzerland) 25 (21) (2020)
Gulsen Akalin Ciftci, Belgin Sever, Mehlika Dilek Altintop
Comprehensive Study on Thiadiazole-Based Anticancer Agents Inducing Cell Cycle Arrest and Apoptosis/Necrosis Through Suppression of Akt Activity in Lung Adenocarcinoma and Glioma Cells. Turkish journal of pharmaceutical sciences 16 (2) (2019)
Halide Edip Temel, Mehlika Dilek Altintop, Ahmet Özdemir
Synthesis and Evaluation of a New Series of Thiazolyl-pyrazoline Derivatives as Cholinesterase Inhibitors. Turkish journal of pharmaceutical sciences 15 (3) (2018)
Ahmet Özdemir, Belgin Sever, Mehlika Dilek Altintop, Elif Kaya Tilki, Miriş Dikmen
Design, Synthesis, and Neuroprotective Effects of a Series of Pyrazolines against 6-Hydroxydopamine-Induced Oxidative Stress. Molecules (Basel, Switzerland) 23 (9) (2018)
Mehlika Dilek Altintop, Belgin Sever, Gülşen Akalın Çiftçi, Ahmet Özdemir
Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors. Molecules (Basel, Switzerland) 23 (6) (2018)